Research identifies novel peptoids with potent antiviral activity against HSV-1 and SARS-CoV-2
Antiviral peptoids are being developed by Maxwell Biosciences to treat recurrent herpes labialis
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.